Document:

Exhibit 10.1

 

EMPLOYMENT AGREEMENT

 

This Employment Agreement (the “Agreement”) is entered into by and between HERITAGE COMMERCE CORP,  a California bank holding company (the “Company”), HERITAGE BANK OF COMMERCE, a California banking corporation (the “Bank”), and KEITH WILTON, an individual (the “Executive”) as of August 8, 2019 (the “Effective Date”).  This Agreement replaces any previous employment agreements between the parties and makes such previous agreements null and void.

 

RECITALS

 

WHEREAS, the Company is a California corporation and a bank holding Company registered under the Bank Holding Company Act of 1956, as amended, subject to the supervision and regulation of the Board of Governors of the Federal Reserve System,

 

WHEREAS, the Company is the parent holding company for the Bank, which is a California banking association, subject to the supervision and regulation of the California Department of Financial Institution and the Federal Reserve Board,

 

WHEREAS, the Board of Directors of the Company and the Bank have approved and authorized the entry into this Agreement with the Executive; and

 

WHEREAS, the parties desire to enter into this Agreement to set forth the terms and conditions for the employment relationship of the Executive with the Company and the Bank.

 

AGREEMENT

 

NOW, THEREFORE, in consideration of the promises and mutual covenants and agreements herein contained and intending to be legally bound hereby, the Company, the Bank and the Executive hereby agree as follows:

 

1.                                      Employment.

 

1.1                               Title.  The Executive is employed as the Chief Executive Officer and President of the Company and the Bank.  In this capacity, the Executive shall have such duties and responsibilities as may be designated by the Board of Directors of the Company and the Bank in accordance with the objectives or policies of the Board of Directors of the Company and the Bank, from time to time, in connection with the business activities of the Company and the Bank.

 

1.2                               Devotion to Bank Business.  The Executive shall devote Executive’s full business time, ability, and attention to the business of the Company and the Bank during the term of this Agreement and shall not during the term of this Agreement engage in any other business activities, duties, or pursuits whatsoever, or directly or indirectly render any services of a business, commercial, or professional nature to any other person or organization, whether for compensation or otherwise, without the prior written consent of the Board of Directors of the Company and the Bank.  It shall not be a violation of this Agreement for the Executive to (i) serve on corporate, civic or charitable boards or committees, (ii) deliver lectures, fulfill speaking engagements or teach at educational institutions and (iii) manage personal investments, so long as such activities do not

 

1

 

significantly interfere with the performance of the Executive’s responsibilities as an employee of the Company and the Bank in accordance with this Agreement.  Nothing in this Agreement shall be interpreted to prohibit the Executive from making passive personal investments.  However, the Executive shall not directly or indirectly acquire, hold, or retain any interest in any business competing with or similar in nature to the business of the Bank and the Company, except as permitted by Company policies or authorized by the Board of Directors of the Company and the Bank.

 

1.3                               Standard.  The Executive will set a high standard of professional conduct given the Executive’s role with the Company and the Bank and the Executive’s responsibility relative to the Company’s and the Bank’s presence and stature in the community.  The Executive will, at all times, emulate this high professional standard of conduct in order to develop and enhance the Company’s and the Bank’s reputation and image.  The Executive will comply with all applicable rules, policies and procedures of the Company and the Bank and any of its subsidiaries and all pertinent regulatory standards as may affect the Company and the Bank.

 

1.4                               Location.  The Executive shall provide services for the Company and the Bank at their principal executive offices located in San Jose, California.  The Executive agrees that the Executive will be regularly present at the Company’s principal executive offices and that the Executive may be required to travel from time to time in the course of performing the Executive’s duties for the Company and the Bank.

 

1.5                               No Breach of Contract.  The Executive hereby represents to the Company and the Bank that:  (i) the execution and delivery of this Agreement by the Executive and the performance by the Executive of the Executive’s duties hereunder shall not constitute a breach of, or otherwise contravene, the terms of any other agreement or policy to which the Executive is a party or by which the Executive is otherwise bound; (ii) that the Executive has no information (including, without limitation, confidential information or trade secrets) of any other person or entity which the Executive is not legally and contractually free to disclose the Company and the Bank; and (iii) that except as disclosed (and provided copies) the Executive is not bound by any confidentiality, trade secret or similar agreement (other than this Agreement) with any other person or entity.

 

2.                                      Term.  The term of this Agreement shall be a period of one (1) year from the Effective Date, subject to the termination provisions of Section 6.  Upon the occurrence of the first annual anniversary of the Effective Date, and on each anniversary date thereafter, the term of this Agreement shall be deemed automatically extended for an additional one (1) year term, subject to the termination provisions of Section 6.

 

3.                                      Compensation.

 

3.1                               Salary.  The Executive shall receive a salary at an annual rate of $500,000 which will be paid in accordance with the Company’s and the Bank’s normal payroll procedures including applicable adjustments for withholding taxes.  The Executive shall receive such annual increases in salary, if any, as may be determined by the Company’s Board of Directors annual review of the Executive’s compensation each year during the term of this Agreement.  Participation

 

2

 

in deferred compensation, discretionary or performance bonus, retirement, stock option and other employee benefit plans and in fringe benefits shall not reduce the annual rate.

 

3.2                               Incentive Compensation.  The Executive shall be entitled to qualify for an annual incentive compensation payment pursuant to the terms of the Company’s Proxy Level Officer Bonus Plan in effect at the date of this Agreement, and as amended at any future date or pursuant to any successor incentive plan or arrangement adopted by the Company or the Bank for its officers (the “Incentive Plan”).  Notwithstanding any terms of the Incentive Plan to the contrary, an annual payment if earned under the Incentive Plan for a fiscal year shall be paid to the Executive no later than the 15th day of the third month following the end of the calendar year in which the annual incentive compensation payment is no longer subject to a substantial risk of forfeiture.  Except as set forth in the Incentive Plan or this Agreement, or in any successor incentive plan or arrangement, no incentive compensation payments shall be prorated for a partial year during the year the Executive’s employment is terminated and the Executive shall not be entitled to receive incentive compensation payments for any year during the term of this Agreement in which Executive was not employed by the Company or the Bank for the full fiscal year.

 

3.3                               Other Benefits.  The Executive shall be entitled to those benefits adopted by the Bank and the Company for all executive officers of the Company or the Bank, subject to applicable qualification requirements and regulatory approval requirements, if any.  To the extent that the level of such benefits is based on seniority or compensation levels, the Company and the Bank shall make appropriate and proportionate adjustments to the Executive’s benefits.  The Executive shall be further entitled to the following additional benefits which shall supplement or replace, to the extent duplicative of any part or all of the general officer benefits, the benefits otherwise provided to the Executive:

 

(a)                                 Automobile Allowance And Insurance.  The Bank will pay to the Executive an automobile allowance in the amount of $1,000 per month during the term of this Agreement.  The Bank shall reimburse the Executive for gasoline and maintenance expenditures related to use of the automobile acquired or used by the Executive upon presentation and approval of receipts, invoices or other appropriate evidence of such expense in accordance with the policies of the Bank.  The Executive shall obtain and maintain public liability insurance and property damage insurance policies with insurer(s) acceptable to the Bank with such coverages in such amounts as may be acceptable to the Bank  from time to time.  The Bank may elect to provide and pay for such insurance policies in lieu of the Executive maintaining such policies.

 

(b)                                 Vacation.  The Executive shall be entitled to 25 paid vacation days for each calendar year (reduced pro rata for any partial year), of which at least 10 days (reduced pro rata for any partial year) must be taken consecutively.  Vacation may be accrued in accordance with the Company’s or Bank’s policy.

 

(c)                                  Insurance.  Except as provided in the last sentence of this Section 3.3(c), the Bank or the Company shall provide during the term of this Agreement at no cost to the Executive group life, health (including medical, dental, vision and hospitalization), accident and disability insurance coverage for the Executive and the Executive’s dependents through a policy or policies provided by the insurer(s) selected by the Company or the Bank in their sole discretion on the same basis as all other executives in comparable positions with the Bank.  If the Company or Bank

 

3

 

determines that any applicable laws or regulations, including the implementation of the federal Affordable Care Act, materially increases the costs of health insurance to the Company or the Bank, the Company or Bank, notwithstanding the prior sentence may require the Executive to pay some or all of the costs related to the Executive and the Executive’s dependents health care insurance coverage.

 

(d)                                 401(k).  The Company maintains a 401(k) plan for its eligible employees.  Subject to the terms and conditions set forth in the official plan documents, the Executive will be eligible to participate in the 401(k) plan, and shall receive a matching contribution in accordance with the terms of the 401(k) plan from the Company.

 

(e)                                  Employee Stock Ownership Plan.  The Executive will be eligible to participate in the Company’s Employee Stock Ownership Plan (“ESOP”), subject to the terms and conditions of the ESOP.

 

(f)                                   Reimbursement for Tax Preparation.  The Bank will reimburse the Executive for up to $1,200 of expense incurred by the Executive for tax consultation and preparation of tax returns, upon presentation and approval of receipts, invoices or other appropriate evidence of such expense in accordance with policies of the Bank.

 

(g)                                  Annual Physical Exam.  The Bank shall pay or reimburse the Executive of the cost, if any, in excess of applicable insurance coverage specified in Section 3.3(c) for an annual physical examination conducted by a licensed physician(s) selected by the Executive, the results of which examination shall not be required to be disclosed to the Bank.  Any such reimbursement shall be made upon presentation and approval of receipts, invoices or other appropriate evidence of such expense in accordance with policies of the Bank.

 

3.4                               Business Expenses/Memberships.  The Executive shall be entitled to incur and be reimbursed for all reasonable business expenses, including for monthly dues for membership to one Country Club selected by Executive and for the monthly dues for The Capital Club, (but not any amount attributable to or payable for initiation fees or capital improvement costs or fees).  The Bank shall reimburse the Executive for all such expenses upon the presentation by the Executive, from time to time, of an itemized account of such expenditures setting forth the date, the purposes for which incurred, and the amounts thereof, together with such receipts showing payments in conformity with the Bank’s established policies.  Reimbursement shall be made within a reasonable period after the Executive’s submission of an itemized account in accordance with the Bank’s policies.

 

4.                                      Indemnity.  The Bank and the Company shall indemnify and hold the Executive harmless from any cost, expense or liability arising out of or relating to any acts or decisions made by the Executive on behalf of or in the course of performing services for the Company and the Bank to the same extent the Bank and the Company indemnifies and holds harmless other executive officers and directors of the Company and the Bank and in accordance with the articles of incorporation, bylaws and established policies of the Bank and the Company.

 

4

 

5.                                      Certain Terms Defined.  For purposes of this Agreement:

 

5.1                               “Accrued Obligations” means the sum of the Executive’s Base Salary and accrued vacation through the Date of Termination to the extent not theretofore paid, outstanding expense reimbursements and any compensation previously deferred by the Executive to the extent not theretofore paid.

 

5.2                               “Average Annual Bonus” means the average bonus or incentive compensation amount paid to (or earned by) the Executive in any of the three (3) fiscal years (including the period of employment with the Bank and Company prior to the Effective Date) immediately preceding the Termination Date.

 

5.3                               “Base Salary” means, as of any Date of Termination of employment, the current annual salary of the Executive.

 

5.4                               “Cause” means (i) the Executive willfully breaches or habitually neglects the duties which the Executive is required to perform under this Agreement; (ii) the Executive commits an intentional act of moral turpitude that has a material detrimental effect on the reputation or business of the Bank or the Company; (iii) the Executive is convicted of a felony or commits any material and actionable act of dishonesty, fraud, or intentional material misrepresentation in the performance of the Executive’s duties under this Agreement; (iv) the Executive engages in an unauthorized disclosure or use of inside information, trade secrets or other confidential information; or (v) the Executive willfully breaches a fiduciary duty, or violates any law, rule or regulation, which breach or violation results in a material adverse effect on the Company and the Bank (taken as a whole).  If the Company or Bank decides to terminate the Executive’s employment for Cause, the Company or Bank will provide the Executive with notice specifying the grounds for termination, accompanied by a brief written statement stating the relevant facts supporting such grounds.

 

5.5                               “Change of Control” means, subject to the limitations of Section 409A of the Code, set forth in Section 7 of this Agreement, the earliest occurrence of one of the following events:

 

(a)                                 the acquisition (or acquisition during the 12 month period ending on the date of the most recent acquisition) by any individual, entity, or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (a “Person”) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 40% or more of either (i) the then outstanding shares of common stock of the Company (the “Outstanding Company Common Stock”) or (ii) the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors (“Outstanding Company Voting Securities”); provided, however, that for purposes of this subsection (a), the following acquisitions shall not constitute a Change of Control:  (i) any acquisition directly from the Company, (ii) any acquisition by the Company that reduces the number of shares issued and outstanding through a stock repurchase program or otherwise, (iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or the Bank or any corporation controlled by the Company or the Bank or (iv) any

 

5

 

acquisition by any corporation pursuant to a transaction which complies with clauses (i), (ii) and (iii) of subsection (c) of this Section 5.4; or

 

(b)                                 individuals who, as of the Effective Date, constitute the Board of Directors of the Company (the “Incumbent Board”) cease for any reason other than resignation, death or disability to constitute at least a majority of the Company’s Board of Directors during any 12 month period; provided, however, that any individual becoming a director subsequent to the Effective Date whose election, or nomination for election by the Company’s shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Company’s Board of Directors; or

 

(c)                                  consummation of a reorganization, merger or consolidation of the Company or the Bank, or sale or other disposition (in one transaction or a series of transactions) of any assets of the Bank or the Company having a total fair market value equal to, or more than, 40% of the total gross fair market value of all of the assets of the Bank or the Company immediately prior to such acquisition or acquisitions (a “Business Combination”), in each case, unless, following such Business Combination, (i) all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the Outstanding Common Stock and Outstanding Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of, respectively, the then outstanding shares of common stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the corporation resulting from such Business Combination (including, without limitation, a corporation which as a result of such transaction owns all or substantially all of the Company’s or Bank’s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership, immediately prior to such Business Combination of the Outstanding Common Stock and Outstanding Voting Securities, as the case may be, (ii) no Person (excluding any corporation resulting from such Business Combination or any employee benefit plan (or related trust) of the Company or the Bank or such corporation resulting from such Business Combination) beneficially owns, directly or indirectly, 20% or more of, respectively, of the then outstanding shares of common stock of the corporation resulting from such Business Combination or the combined voting power of the then outstanding voting securities of such corporation except to the extent that such ownership existed prior to the Business Combination, and (iii) at least a majority of the members of the board of directors of the corporation resulting from such Business Combination were members of the Company’s Board of Directors at the time of the execution of the initial agreement, or of the action of the Company’s Board of Directors, providing for such Business Combination; or

 

(d)                                 approval by the shareholders of the Company of a complete liquidation or dissolution of the Company.

 

5.6                               “Code” means the Internal Revenue Code of 1986, as amended and any successor provisions to such sections.

 

6

 

5.7                               “Change of Control Period” means the period of time (a) commencing on the earlier of (i) 120 days before the date the Change of Control occurs, or if earlier, 120 days before a definitive agreement is executed by the Company or the Bank for a transaction described in Section 5.4(c) (provided, however, that in the event of this subsection (a)(i) the Executive reasonably demonstrates that the Executive’s termination of employment should it occur was either (x) at the request of a third party who has taken steps reasonably calculated to effect a change in control, or (y) otherwise arose in connection with a Change in Control), or (ii) the date the Change of Control occurs, and (b) ending on the last day of the 24th calendar month immediately following the month the Change of Control occurred.

 

5.8                               “Date of Termination” means (i) if the Executive’s employment is terminated due to the Executive’s death, the Date of Termination shall be the date of death; (ii) if the Executive’s employment is terminated due to Disability, the Date of Termination is the Disability Effective Date; (iii) if the Executive’s employment is terminated by the Bank or the Company for Cause, the Date of Termination is the date on which the Bank or the Company gives notice to the Executive of such termination; (iv) if the Executive’s employment is terminated by the Bank or the Company without Cause or voluntarily by the Executive, the Date of Termination shall be the date specified in the notice of termination; and (v) if the Executive’s employment terminates for any other reason, the Date of Termination shall be the Executive’s final date of employment.

 

5.9                               “Disability” means a physical or mental condition of the Executive which occurs and persists and which, in the written opinion of a physician selected by the Company or the Bank or its insurers and acceptable to the Executive or the Executive’s legal representative, and, in the written opinion of such physician, the condition will render the Executive unable to return to the Executive’s duties for an indefinite period of not less than 180 days.

 

5.10                        “Good Reason” means:

 

(i)                                     any material adverse change in the salary, incentive compensation, benefits, status, responsibilities, authority, and duties (including offices held, titles and reporting requirements) of the Executive, as contemplated by Section 1 of this Agreement;

 

(ii)                                  any failure by the Company or Bank to comply with any of the provisions of Sections 3 or 4 of this Agreement, other than an isolated, insubstantial and inadvertent failure not occurring in bad faith and which is remedied by the Company or Bank promptly after receipt of notice thereof given by the Executive;

 

(iii)                               the Company’s requiring the Executive to be based at any office or location that increases the Executive’s current commute (as of the Effective Date) from his principal residence to the location provided in Section 1.4 of this Agreement by more than 30 miles;

 

(iv)                              any purported termination by the Company or the Bank of the Executive’s employment otherwise than as expressly permitted by this Agreement; or

 

(v)                                 any failure by the Company or the Bank to comply with and satisfy Section 8 of this Agreement.

 

7

 

For purposes of this Section 5.10 any reasonable good faith determination of “Good Reason” made by the Executive shall be conclusive.

 

6.                                      Termination.

 

6.1                               This Agreement may be terminated for the following reasons:

 

(a)                                 Death.  This Agreement shall terminate automatically upon the Executive’s death.

 

(b)                                 Disability.  In the event of the Executive’s Disability, the Company or the Bank may give the Executive a notice of termination.  In such event, the Executive’s employment with the Company and the Bank and this Agreement shall terminate without further act of the parties effective 30 days after receipt of such notice by the Executive (the “Disability Effective Date”) provided, however, that within the 30 days after such receipt, the Executive shall not have returned to full-time performance of the Executive’s duties.  Unless otherwise agreed in writing between the Executive, the Company and the Bank, the Executive shall immediately cease performing and discharging the duties and responsibilities of the Executive’s positions and remove the Executive’s personal belongings from the Company’s and the Bank’s premises.  All rights and obligations accruing to the Executive under this Agreement shall cease at such termination, except that such termination shall not prejudice the Executive’s rights regarding employment benefits which shall have accrued prior to such termination, and any other remedy which the Executive may have at law, in equity or under this Agreement, which remedy accrued prior to such termination.

 

(c)                                  Cause.  The Company or the Bank may terminate the Executive’s employment and this Agreement for Cause.  Unless otherwise agreed in writing between the Executive, the Company and the Bank, the Executive shall immediately cease performing and discharging the duties and responsibilities of the Executive’s positions and remove the Executive’s personal belongings from Company’s and the Bank’s premises.  All rights and obligations accruing to the Executive under this Agreement shall cease at such termination, except that such termination shall not prejudice the Executive’s rights regarding employment benefits which shall have accrued prior to such termination, and any other remedy which the Executive may have at law, in equity or under this Agreement, which remedy accrued prior to such termination.

 

(d)                                 Termination by Bank or the Company Without Cause.  Subject to the last sentence of this Section 6.1(d), the Company or the Bank may, at its election and in its sole discretion, terminate the Executive’s employment and this Agreement at any time and for any reason or for no reason, upon 30 days prior written notice to the Executive, without prejudice to any other remedy to which the Company or the Bank may be entitled either at law, in equity or under this Agreement.  Unless otherwise agreed in writing between the Executive, the Company and the Bank, the Executive shall immediately cease performing and discharging the duties and responsibilities of the Executive’s positions and remove the Executive’s personal belongings from the Company’s and the Bank’s premises.  All rights and obligations accruing to the Executive under this Agreement shall cease at such termination, except that such termination shall not prejudice the Executive’s rights regarding employment benefits which shall have accrued prior to such termination, including the right to receive the severance benefits specified in Section 6.2(a)

 

8

 

or 6.2(b) below, and any other remedy which the Executive may have at law, in equity or under this Agreement, which remedy accrued prior to such termination.  For the avoidance of doubt, if the Company terminates the Executive, but the Executive remains an employee of the Bank, termination by the Company shall not be deemed a termination without cause for purposes of Section 6.2(a) or Section 6.2(b) or constitute a termination of this Agreement.

 

(e)                                  Voluntary Termination by Executive.  The Executive may terminate the Executive’s employment and this Agreement at any time and for any reason or no reason, upon 30 days prior written notice to the Company and the Bank.  Unless otherwise agreed in writing between the Executive, the Company and the Bank, the Executive shall immediately cease performing and discharging the duties and responsibilities of the Executive’s positions and remove the Executive’s personal belongings from the Company’s and the Bank’s premises.  All rights and obligations accruing to the Executive under this Agreement shall cease at such termination, except that such termination shall not prejudice the Executive’s rights regarding employment benefits which shall have accrued prior to such termination and any other remedy which the Executive may have at law, in equity or under this Agreement, which remedy accrued prior to such termination.

 

(f)                                   Termination by the Executive for Good Reason.  The Executive may resign the Executive’s employment from the Company and Bank due to a Good Reason (i) if the Company or the Bank has not cured or remedied the event giving rise to the Good Reason within thirty 30 days after its receipt of a written notice from the Executive stating the Executive’s belief that a Good Reason event exists;  and (ii) such written notice is provided to the Company within 30 days of the purported Good Reason event and describes in detail the basis and underlying facts supporting the Executive’s belief that a Good Reason event has occurred.  Failure to timely provide such written notice to the Company means that the Executive will be deemed to have consented to and irrevocably waived the potential Good Reason event.  If the Company or Bank does timely cure or remedy the Good Reason, then the Executive may either resign employment without it being due to a Good Reason or the Executive may continue to remain employed subject to the terms of this Agreement.  The Company’s receipt of a notification by the Executive of a Good Reason event shall not be deemed to constitute the Company’s acknowledgement, agreement or admission that a Good Reason event has occurred.  If the Executive terminates Executive’s employment and this Agreement pursuant to this Section 6.1(f) unless otherwise agreed in writing between the Executive, the Company and the Bank, the Executive shall immediately cease performing and discharging the duties and responsibilities of Executive’s positions and remove the Executive’s personal belongings from the Company’s and the Bank’s premises.  All rights and obligations accruing to the Executive under this Agreement shall cease at such termination, except that such termination shall not prejudice the Executive’s rights regarding employment benefits which shall have accrued prior to such termination and any other remedy which the Executive may have at law, in equity or under this Agreement, which remedy accrued prior to such termination.

 

6.2                               Certain Benefits upon Termination.

 

(a)                                 Termination Without Cause/Termination for Good Reason.  In the event this Agreement is terminated based on Section 6.1(d) (termination without cause) or Section 6.1(f) (termination for Good Reason), then in such case, the Executive shall receive the Accrued Obligations on the Date of Termination, and severance benefits constituting of:

 

9

 

(i)                                     cash payment in the amount equal to two (2) times the sum of the Executive’s (A) Base Salary and (B) the Average Annual Bonus, payable in a lump sum within 30 days following the Date of Termination, and

 

(ii)                                  continuation of group insurance coverage specified in Section 3.3(c) of this Agreement on terms at least equal to those if the Executive’s employment had not been terminated, but not less favorable than that provided to other executives in comparable positions with the Company or the Bank, for a period of 36months from the Date of Termination, including, continuation of medical coverage for the Executive and the Executive’s dependents pursuant to The Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”), or under applicable California law pursuant to Assembly Bill No. 1401 (“Cal COBRA”), with one hundred percent (100%) of premiums for the insurance coverage payable by the Company or the Bank monthly to the Executive for a period of 36 months from the Date of Termination.  After expiration of the 36 month period, the Executive and the Executive’s dependents shall have such rights to continue to participate under the Company’s or the Bank’s group insurance coverage specified in Section 3.3(c) (subject to the last sentence of Section 3.3(c)) at the Executive’s expense to the extent available under the terms of the plan or benefit.  The Executive agrees to notify the Company or the Bank as soon as practicable, but not less than 10 business days in advance of the commencement of comparable insurance coverage with another employer.  The Company’s and Bank’s obligation for the 36 month period specified herein with respect to the foregoing benefits shall be limited to the extent that the Executive obtains any such benefits pursuant to a subsequent employer’s benefit plans, in which case the Company or the Bank may reduce the coverage of any benefits it is required to provide the Executive hereunder so long as the aggregate coverage and benefits of the combined benefit plans of the new employer are not substantially less favorable to the Executive than the coverage and benefits required to be provided hereunder.

 

(iii)                               The Bank shall reimburse Executive up to $5,000 for bona fide, professional out placement services upon presentation of receipts, invoices or other appropriate evidence of such expense in accordance with policies of the Bank.

 

Notwithstanding the foregoing or any other provision of this Agreement, if any part or all of the severance benefits is subject to taxation under Section 409A of the Code, as determined by the Company or the Bank, with the advice of its independent accounting firm or other tax advisors, then the severance benefits shall be subject to modification as set forth in Section 7 of this Agreement.

 

Notwithstanding the foregoing, when the Executive is entitled to the severance benefits provided in Section 6.2(b), then Executive shall not be entitled to the severance benefits pursuant to this Section 6.2(a).

 

The Executive acknowledges and agrees that severance benefits pursuant to this Section 6.2(a) are in lieu of all damages, payments and liabilities on account of the early termination of this Agreement and are the sole and exclusive remedy for the Executive for a termination specified in Section 6.1(d) or Section 6.1(f).

 

(b)                                 Termination and Change in Control.  In the event of a Change in Control and at any time during the Change of Control Period (x) the Executive’s employment is terminated,

 

10

 

or (y) the Executive voluntarily terminates the Executive’s employment and this Agreement for Good Reason, then the Executive shall receive the Accrued Obligations on the Date of Termination, and the severance benefits consisting of:

 

(i)                                     a cash payment in an amount equal to two  and three-fourths (2.75) times the sum of the Executive’s (A) Base Salary and (B) Average Bonus, payable in a lump sum within 30 days following the Date of Termination; and

 

(ii)                                  continuation of group insurance coverage specified in Section 3.3(c) of this Agreement on terms at least equal to those if the Executive’s employment had not been terminated, but not less favorable than that provided to other executives in comparable positions with the Company or the Bank, for a period of 36 months from the Date of Termination, including continuation of medical coverage for the Executive and the Executive’s dependents pursuant to Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”), or under applicable California law pursuant to Assembly Bill No. 1401 (“Cal COBRA”), with one hundred percent (100%) of premiums for the insurance coverage payable by the Company or the Bank monthly to the Executive for a period of 36 months from the Date of Termination.  After such expiration of the 36 month period, the Executive and the Executive’s dependents shall have such rights to continue to participate under the Bank’s or the Company’s group insurance coverage specified in Section 3.3(c) (subject to the last sentence of Section 3.3(c)) at the Executive’s expense to the extent available under the terms of the plan or benefit.  The Executive agrees to notify the Company or the Bank as soon as practicable, but not less than 10 business days in advance of the commencement of comparable insurance coverage with another insurance carrier.  The Company’s or the Bank’s obligation for the 36 month period specified herein with respect to the foregoing benefits shall be limited to the extent that the Executive obtains any such benefits pursuant to a subsequent employer’s benefit plans, in which case the Company or the Bank may reduce the coverage of any benefits it is required to provide the Executive hereunder so long as the aggregate coverage and benefits of the combined benefit plans of the new employer are not substantially less favorable to the Executive than the coverage and benefits required to be provided hereunder.

 

Notwithstanding the foregoing or any other provision of this Agreement, if any part or all of the severance benefits is subject to taxation under Section 409A of the Code, as determined by the Company or the Bank, with the advice of its independent accounting firm or other tax advisors, then the severance payment shall be subject to modification as set forth hereafter in Section 7 of this Agreement.

 

The Executive acknowledges and agrees that severance benefits pursuant to this Section 6.2(b) are in lieu of all damages, payments and liabilities on account of the events described above for which such severance benefits may be due the Executive under Section 6.2(b) of this Agreement.  This Section 6.2(b) shall be binding upon and inure to the benefit of the Bank and the Company and their respective successors and assigns.

 

Notwithstanding the foregoing, the Executive shall not be entitled to receive severance benefits pursuant to this Section 6.2(b) in the event Executive’s termination of employment results from an occurrence described in Sections 6.1(a), 6.1(b) or 6.1(c).

 

11

 

(c)                                  Death.  If the Executive’s employment terminates by reason of the Executive’s death, this Agreement shall terminate without further obligations to the Executive’s legal representatives under this Agreement, other than for payment of Accrued Obligations and any incentive compensation for the year in which the death occurred prorated through the Date of Termination.  Accrued Obligations shall be paid to the Executive’s estate or beneficiary, as applicable, in a lump sum in cash within 30 days of the Date of Termination; provided, however, that payment may be deferred until the Executive’s executor or personal representative has been appointed and qualified pursuant to the laws in effect in the Executive’s jurisdiction of residence at the time of the Executive’s death.  The Executive’s estate and/or beneficiaries shall be entitled to receive, benefits at least equal to the most favorable benefits provided by the Company and the Bank to the estate and beneficiaries of other executives in comparable positions with the Company and the Bank under such plans, programs, practices and policies relating to death benefits, if any, as in effect on the date of the Executive’s death.

 

(d)                                 Disability.  If the Executive’s employment terminates by reason of the Executive’s Disability, this Agreement shall terminate without further obligations to the Executive under this Agreement, other than for payment of Accrued Obligations, and any incentive compensation for the year in which the termination occurs prorated through the Date of Termination and any benefits under such plans, programs, practices and policies relating to disability benefits, if any, as in effect on the Date of Termination.

 

(e)                                  Cause/Voluntary Termination.  If the Executive’s employment terminates for Cause, this Agreement shall terminate without further obligations to the Executive other than the obligation to pay to the Executive the Accrued Obligations.  If the Executive’s employment terminates due to the Executive’s voluntarily termination this Agreement, except as provided in Section 6.1(f) or clause (y) of the first paragraph of Section 6.2(b), this Agreement shall terminate without further obligations to the Executive other than the obligation to pay to the Executive the Accrued Obligations.

 

(f)                                   Single Trigger Event.  The provisions for payments contained in this Section 6.2 may be triggered only once during the term of this Agreement, so that, for example, should the Executive be terminated without cause and should there thereafter be a Change of Control, then the Executive would be entitled to be paid only under Section 6.2(b) and not under Section 6.2(a), as well. In addition, the Executive shall not be entitled to receive severance benefits of any kind from any parent, wholly owned subsidiary or other affiliated entity of the Company or the Bank if in connection with the same event of series of events the payments provided for in this Section 6.2 has been triggered.

 

7.                                      Section 409A Limitation/Section 280(g).

 

(a)                                 Section 409A.  It is the intention of the Company, the Bank, and the Executive that the severance benefits payable to the Executive under Section 6.2 either be exempt from, or otherwise comply with, Section 409A (“Section 409A”) of the Code.

 

Notwithstanding any other term or provision of this Agreement, to the extent that any provision of this Agreement is determined by the Company or the Bank, with the advice of its independent accounting firm or other tax advisors, to be subject to and not in compliance with

 

12

 

Section 409A, including, without limitation, the definition of Change in Control or the timing of commencement and completion of severance benefits and/or other benefit payments to the Executive hereunder, or the amount of any such payments, such provisions shall be interpreted in the manner required to exempt the benefit from or to comply with Section 409A.  The Company, the Bank and the Executive acknowledge and agree that such interpretation could, among other matters, (i) limit the circumstances or events that constitute a “change in control;” (ii) delay for a period of six months or more, or otherwise modify the commencement of severance and/or other benefit payments; (iii) modify the completion date of severance and/or (iv) other benefit payments and/or reduce the amount of the benefit otherwise provided.

 

The Company, Bank and the Executive further acknowledge and agree that if, in the judgment of the Company or the Bank, with the advice of its independent accounting firm or other tax advisors, amendment of this Agreement is necessary to exempt the benefits from or to comply with Section 409A, the Company, the Bank, and the Executive will negotiate reasonably and in good faith to amend the terms of this Agreement to the extent necessary so that it exempts the benefits from or to comply with Section 409A (with the most limited possible economic effect on the Company, the Bank and the Executive).  For example, if this Agreement is subject to Section 409A and Section 409A requires that severance and/or other benefit payments must be delayed until at least six months after the Executive terminates employment, then the Bank, the Company and the Executive shall delay payments and/or promptly seek a written amendment to this Agreement that would, if permissible under Section 409A, eliminate any such payments otherwise payable during the first six months following the Executive’s termination of employment and substitute therefore a lump sum payment or an initial installment payment, as applicable, at the beginning of the 7th month following the Executive’s termination of employment which, in the case of an initial installment payment, would be equal in the aggregate to the amount of all such payments thus eliminated.  Notwithstanding the foregoing, (a) the Executive and the Executive’s dependents shall not be denied access to and participation in any health or medical insurance coverage and benefits, for any period of time the Executive and the Executive’s dependents are otherwise eligible, and (b) the Executive acknowledges and agrees that the Company or the Bank shall have the exclusive authority to determine whether the Executive is a “specified employee” within the meaning of Section 409A(a)(2)(B)(i).

 

(b)                                 Section 280(g).  If any payment or benefit the Executive would receive in connection with a Change of Control from the Company or otherwise (“Payment”) would (i) constitute a “parachute payment” within the meaning of Section 280G of the Code, and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment will be equal to the Reduced Amount. The “Reduced Amount” will be either (x) the largest portion of the Payment that would result in no portion of the Payment being subject to the Excise Tax or (y) the largest portion, up to and including the total, of the Payment, whichever amount, after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in the Executive’s receipt, on an after-tax basis, of the greater amount of the Payment notwithstanding that all or some portion of the Payment may be subject to the Excise Tax. If a reduction in the Payment constituting “parachute payments” is necessary so that no portion of such  Payment is subject to the Excise Tax, then the reduction shall occur in a manner to maximize the Executive’s after-tax retained value and if necessary to comply with Code Section 409A shall be effected in the following order: first, reduction of cash payments; second, cancellation of accelerated vesting

 

13

 

of stock awards; and third, reduction of employee benefits. The Company shall determine the extent to which the Executive is subject to the Excise Tax in its reasonable discretion and in accordance with the regulations promulgated under Section 280G of the Code.  Notwithstanding the foregoing, the parties will use its good faith efforts to maximize to the extent reasonable the Executive’s after-tax retained value of the payments and benefits the Executive receives in connection with a Change of Control in accordance with the foregoing.

 

8.                                      Assignment.  This Agreement will inure to the benefit of and be binding upon the Bank and the Company and any of their respective successors and assigns.  In view of the personal nature of the services to be performed under this Agreement by the Executive, the Executive will not have the right to assign or transfer any of the Executive’s rights, obligations or benefits under this Agreement.  The Company and the Bank will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company or the Bank to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company and the Bank be required to perform it if no such succession had taken place.  As used in this Agreement, the “Company” or the “Bank” shall mean the Company or the Bank, as applicable, as hereinbefore defined and any successor to the Company’s or Bank’s business and/or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law, or otherwise.

 

9.                                      Specific Performance.  The Executive hereby represents and agrees that the services to be performed under the terms of this Agreement are of a special, unique, unusual, extraordinary, and intellectual character that gives them a peculiar value, the loss of which cannot be reasonably or adequately compensated in damages in an action at law.  The Executive therefore expressly agrees that the Company and the Bank, in addition to any other rights or remedies that the Bank and the Company may possess, shall be entitled to injunctive and other equitable relief to prevent or remedy a breach of this Agreement by the Executive.

 

10.                               Loyalty, Confidentiality and Non-Solicitation by the Executive.

 

(a)                                 Definitions.  The term “Trade Secrets” shall be given its broadest possible interpretation and shall mean any information, including formulas, patterns, compilations, financial reports, customer records, marketing or financial programs, devices, methods, know-how, negative know-how, techniques, discoveries, ideas, concepts, designs, technical information, drawings, data, customer and supplier lists, information regarding customers, buyers and suppliers, distribution techniques, production processes, research and development projects, marketing plans, general financial information and financial information concerning customers, the Company’s or the Bank’s legal, business and financial structure and operations, and other confidential and proprietary information or processes which (i) derive independent economic value, actual or potential, from not being generally known to the public or to other persons who can obtain economic value from its disclosure or use and (ii) are the subject of efforts that are reasonable under the circumstances to maintain its secrecy.

 

The term “Proprietary Information” shall also be given its broadest possible interpretation and shall mean any and all information disclosed or made available by the Company or the Bank to the Executive including, without limitation, any information upon which the Company’s or the Bank’s business or success depends.

 

14

 

(b)                                 The Executive shall not, during the term of this Agreement, directly or indirectly, either as an employee, employer, consultant, agent, principal, stockholder (except as permitted in Section 1.2 of this Agreement), officer, director, or in any other individual or representative capacity, engage or participate in any competitive banking or financial services business without the prior written consent of the Board of Directors of the Company or the Bank.

 

(c)                                  Following termination of this Agreement and the Executive’s employment hereunder, the Executive shall not use any Trade Secret or Proprietary Information of the Bank or the Company or their affiliates and subsidiaries to solicit, directly, indirectly or in any manner whatsoever, (i) any employee of the Bank, the Company or their affiliates and subsidiaries (including any former employees who voluntarily terminated employment with the Bank or the Company within a 12 month period prior to the Executive’s termination of employment) to resign or to apply for or accept employment with any other competitive banking or financial services business within the counties in California in which the Bank has located its headquarters or branch offices, or (ii) any customer, person or entity that has a business relationship with the Bank during the 12 month period prior to the Executive’s termination of employment with the Bank, terminate such business relationship and engage in a business relationship with any other competitive banking or financial services business within the counties in California in which the Bank has located its headquarters or branch offices.

 

11.                               Disclosure of Information.  The Executive shall not, at any time or in any manner, directly or indirectly, either before or after termination of this Agreement, without the prior written consent of the Board of Directors of the Company or except as required by law to comply with legal process including, without limitation, by oral questions, interrogatories, requests for information or documents, subpoena, civil investigative demand or similar process, use for the Executive’s own benefit or the benefit of any other person or entity, or otherwise disclose or communicate to any person or entity including, without limitation, the media or by way of the World Wide Web, any information concerning any Trade Secret or Proprietary Information of the Company or the Bank.  The Executive further recognizes and acknowledges that any Trade Secrets concerning any customers of the Company or the Bank and their respective affiliates and subsidiaries, as it may exist from time to time, is strictly confidential and is a valuable, special and unique asset of the Company’s or the Bank’s.  In the event the Executive is required by law to disclose Trade Secrets or Proprietary Information, the Executive will provide the Company and the Bank, and their counsel with immediate notice of such request so that they may consider seeking a protective order.  If, in the absence of a protective order or the receipt of a waiver hereunder, the Executive is nonetheless, in the written opinion of knowledgeable counsel, compelled to disclose Trade Secrets or Proprietary Information to any tribunal or any other party or else stand liable for contempt or suffer other material censure or material penalty, then the Executive may disclose (on an “as needed” basis only) such information to such tribunal or other party without liability hereunder.  Notwithstanding the foregoing, the Executive may disclose Trade Secrets or Proprietary Information as may be required by any regulatory agency having jurisdiction over the operations of the Company or the Bank in connection with an examination of the Company or the Bank or other proceeding conducted by such regulatory agency.  Under the Defend Trade Secrets Act of 2016 (“DTSA”) an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a federal, state or local government official, either directly or indirectly to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a

 

15

 

complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  In addition, the DTSA provides that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney for the individual and the use of trade secret information in the court proceeding, if the individual (A) files any document containing the trade secret under seal; and (B) does not disclosure the trade secret, except pursuant to court order.

 

12.                               Written, Printed or Electronic Material.  All written, printed or electronic material, notebooks and records including, without limitation, computer disks, cloud-based storage, Blackberry, iPhone, iPad (or similar devices), or lap top used by the Executive in performing duties for the Bank or the Company, other than the Executive’s personal address lists, telephone lists, notes and diaries, are and shall remain the sole property of the Company and the Bank.  Upon termination of employment, the Executive shall promptly return all such material (including all copies, extracts and summaries thereof) to the Bank.

 

13.                               Miscellaneous.

 

13.1                        Notice.  For the purpose of this Agreement, notices and all other communications provided for in this Agreement shall be in writing and shall be deemed to have been duly given when personally delivered or three (3) days after the date of mailing by United States mail, certified or registered, return receipt requested, postage prepaid, addressed to the respective addresses set forth below, or to such other addresses as either party may have furnished to the other in writing in accordance herewith, except that notice of a change of address shall be effective only upon actual receipt:

 

	
Company:
    	
 
    	
HERITAGE COMMERCE CORP
   150 Almaden Blvd.
   San Jose, CA 95113
   Attn: Chairman of the Board of Directors
    
	
 
    	
 
    	
 
    
	
Bank:
    	
 
    	
HERITAGE BANK OF COMMERCE
   150 Almaden Blvd.
   San Jose, CA 95113
   Attn: Chairman of the Board of Directors
    
	
 
    	
 
    	
 
    
	
with a copy to:
    	
 
    	
Buchalter , A Professional Corporation
   1000 Wilshire Boulevard, Suite 1500
   Los Angeles, CA 90017-2457
   Attn: Mark A. Bonenfant, Esq.
    
	
 
    	
 
    	
 
    
	
Executive:
    	
 
    	
Keith Wilton
   150 Almaden Boulevard
   San Jose, CA 95113
    

 

13.2                        Amendments or Additions.  No amendment, modification or additions to this Agreement shall be binding unless in writing and signed by the parties hereto.

 

16

 

13.3                        Section Headings.  The section headings used in this Agreement are included solely for convenience and shall not affect, or be used in connection with, the interpretation of this Agreement.

 

13.4                        Severability.  The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof.

 

13.5                        Counterparts.  This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but both of which together will constitute one and the same instrument.

 

13.6                        Mediation.  Prior to engaging in any legal or equitable litigation or other dispute resolution process, regarding any of the terms and conditions of this Agreement between the parties, or concerning the subject matter of the Agreement between the parties, each party specifically agrees to engage in good faith, in a mediation process at the expense of the Bank or the Company, complying with the procedures provided for under California Evidence Code Sections 1115 through and including 1125, as then currently in effect.  The parties further and specifically agree to use their best efforts to reach a mutually agreeable resolution of the matter.  The parties understand and specifically agree that should any party to this Agreement refuse to participate in mediation for any reason, the other party will be entitled to seek a court order to enforce this provision in any court of appropriate jurisdiction requiring the dissenting party to attend, participate, and to make a good faith effort in the mediation process to reach a mutually agreeable resolution of the matter.

 

13.7                        Arbitration.  To the extent not resolved through mediation as provided in Section 13.6, all claims, disputes and other matters in question arising out of or relating to this Agreement, any termination of the Executive’s employment, the enforcement or interpretation of this Agreement, or because of an alleged breach, default, or misrepresentation in connection with any of the provisions of this Agreement, including (without limitation) any state or federal statutory claims, shall be resolved by binding arbitration in Santa Clara County, California, before a sole arbitrator (the “Arbitrator”) mutually selected by the parties from Judicial Arbitration and Mediation Services (“JAMS”) in accordance with the rules and procedures of JAMS then in effect.  If JAMS is no longer able to supply the arbitrator, such arbitrator shall be mutually selected from the American Arbitration Association (“AAA”).  The obligation of the parties to arbitrate pursuant to this clause shall be specifically enforced in accordance with, and shall be conducted consistently with the provisions of Title 9 of Part 3 of the California Code of Civil Procedure as the exclusive remedy of such dispute; provided, however, that provisional injunctive relief may, but need not, be sought in a court of law while arbitration proceedings are pending, and any provisional injunctive relief granted by such court shall remain effective until the matter is finally determined by the Arbitrator.  Final resolution of any dispute through arbitration may include any remedy or relief that the Arbitrator deems just and equitable, including any and all remedies provided by applicable state or federal statutes.  At the conclusion of the arbitration, the Arbitrator shall issue a written decision that sets forth the essential findings and conclusions upon which the Arbitrator’s award or decision is based.  Any award or relief granted by the Arbitrator hereunder shall be final and binding on the parties hereto and may be enforced by any court of competent jurisdiction.

 

17

 

13.8                        Attorneys Fees.  In the event of litigation, arbitration or any other action or proceeding between the parties to interpret or enforce this Agreement, or any part thereof or relating to this Agreement, the prevailing party shall be entitled to recover its costs related to such action or proceeding and its reasonable fees of attorneys, accountants and expert witnesses incurred by such party in connection with any such action or proceedings.  The prevailing party shall be deemed to be the party which obtains substantially the relief sought by final resolution, compromise or settlement, or as may otherwise be determined by order of a court of competent jurisdiction in the event of litigation, an award or decision of an arbitrator in the event of arbitration.

 

13.9                        Entire Agreement.  This Agreement supersedes any and all agreements, either oral or in writing, between the parties with respect to the employment of the Executive by the Company and the Bank and contains all of the covenants and agreements between the parties with respect to the employment of the Executive by the Company and the Bank.  Each party to this Agreement acknowledges that no other representations, inducements, promises, or agreements, oral or otherwise, have been made by any party, or anyone acting on behalf of any party, which are not set forth herein, and that no other agreement, statement, or promise not contained in this Agreement shall be valid or binding on either party.

 

13.10                 Waiver.  The failure of a party to insist on strict compliance with any of the terms, provisions, covenants, or conditions of this Agreement by another party shall not be deemed a waiver of any term, provision, covenant, or condition, individually or in the aggregate, unless such waiver is in writing, nor shall any waiver or relinquishment of any right or power at any one time or times be deemed a waiver or relinquishment of that right or power for all or any other times.

 

13.11                 Severability.  If any provision in this Agreement is held by a court of competent jurisdiction or arbitrator to be invalid, void, or unenforceable, the remaining provisions shall nevertheless continue in full force and effect without being impaired or invalidated in any way.  Any provision of this Agreement held invalid or unenforceable only in part or degree will remain in full force and effect to the extent not held invalid or unenforceable.

 

13.12                 Interpretation.  This Agreement shall be construed without regard to the party responsible for the preparation of the Agreement and shall be deemed to have been prepared jointly by the parties.  Any ambiguity or uncertainty existing in this Agreement shall not be interpreted against any party, but according to the application of other rules of contract interpretation, if an ambiguity or uncertainty exists.

 

13.13                 Governing Law and Venue.  The laws of the State of California, other than those laws denominated choice of law rules, shall govern the validity, construction and effect of this Agreement.  Any action which in any way involves the rights, duties and obligations of the parties hereunder and is not resolved by binding arbitration shall be brought in the courts of the State of California and venue for any action or proceeding shall be in Santa Clara County or in the United States District Court for the Northern District of California, and the parties hereby submit to the personal jurisdiction of said courts.

 

13.14                 Payments Due Deceased Executive.  If the Executive dies prior to the expiration of the term of the Executive’s employment (except termination resulting from such death), any

 

18

 

payments that may be due the Executive from the Bank or the Company under this Agreement as of the date of death shall be paid to the Executive’s heirs, beneficiaries, successors, permitted assigns or transferees, executors, administrators, trustees, or any other legal or personal representatives.

 

13.15                 Effect of Termination on Certain Provisions.  Upon the termination of this Agreement, the obligations of the Bank, the Company and the Executive hereunder shall cease except to the extent of the Bank’s or the Company’s obligation to make payments, if any, to or for the benefit of the Executive following termination, and provided that this Section 13.15 and Sections 4, 6.2, 7, 8, 9, 10, 11, 12, and 13.1 through 13.14 shall remain in full force and effect.

 

13.16                 Advice of Counsel and Advisors.  The Executive acknowledges and agrees that he has read and understands the terms and provisions of this Agreement and prior to signing this Agreement, Executive has had the advice of counsel and/or such other advisors as Executive deemed appropriate in connection with the Executive’s review and analysis of such terms and provisions of this Agreement.

 

IN WITNESS WHEREOF, each of the parties hereto has executed this Agreement on the date first indicated above.

 

	
 
    	
“COMPANY”
    
	
 
    	
 
    
	
 
    	
HERITAGE   COMMERCE CORP,
    
	
 
    	
a California bank   holding company
    
	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ Walter Kaczmarek
    
	
 
    	
 
    	
Walter Kaczmarek,
    
	
 
    	
 
    	
Chief Executive   Officer and President
    
	
 
    	
 
    
	
 
    	
“BANK”
    
	
 
    	
 
    
	
 
    	
HERITAGE   BANK OF COMMERCE,
    
	
 
    	
a California   banking corporation
    
	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ Walter Kaczmarek
    
	
 
    	
 
    	
Walter Kaczmarek,
    
	
 
    	
 
    	
Chief Executive   Officer
    
	
 
    	
 
    
	
 
    	
“EXECUTIVE”
    
	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ Keith Wilton
    
	
 
    	
 
    	
Keith Wilton
    

 

19Exhibit

Exhibit 10.21

Employment Agreement
between
Hans Geiselhöringer
Hohenzollemstrasse 146
80796 München
Germany
(hereinafter referred to as ‘Executive’)
and
Nobel Biocare Services AG
Postfach
8058 Zurich-Flughafen
Switzerland
(hereinafter referred to as ‘Employer’)

The Executive and the Employer are hereinafter jointly referred to as the ‘Parties’.
Nobel Biocare Services AG and any of its affiliated companies are hereinafter jointly referred to as ‘Nobel Biocare Group’.
1.    Function, Scope of Employment and Duties
The Executive is employed as Executive Vice President Global Research, Products & Development.
The Executive reports to the CEO.  The Executive shall carefully perform the duties normally associated with the position of Executive Vice President Global Research, Products & Development and such other duties and responsibilities assigned to him from time to time by the CEO.
Place of work is mainly Zurich.  However, Executive shall be required to travel regularly.
During the term of his employment, Executive shall not directly or indirectly participate in any company, which competes with Nobel Biocare Group.  Executive may however, buy and hold participations in listed companies, as long as these investments stay within reasonable bounds and do not provide Executive with the opportunity to influence the management of such a listed company competing with Employer.
2.    Start of Work, Employment Term 
This Agreement is valid as of the execution date and concluded for an Indefinite period of time.  The notice period shall be 6 months.  The termination notice shall be in writing.  There is no probation period.
Employer reserves the right to terminate Executive’s employment contract without notice or payment in lieu of notice in the case of gross misconduct.  Employer reserves the right to require Executive not to carry out his duties or attend place of work during the period of notice.  In such circumstances, Executive will however, be expected to be available during hours the employer require this.  At the absolute discretion of the Employer, payment in lieu of notice may be made.

Employment Agreement - Hans Geiselhöringer                            

3.    Annual Based Salary
Executive shall be entitled to a fixed gross salary of CHF 695’250 per year (Annual Base Salary) payable after deduction of Executive’s contributions to the social insurances and pensions scheme under applicable laws and regulations, in twelve identical installments at the end of each calendar month.
The Annual Base Salary compensates for the entire working time necessary for carrying out and performing the duties and obligations of Executive’s position and function.  Overtime compensation is explicitly included in the Annual Base Salary.
4.    Short Term Incentive
Provided that the goals set by Employer (as described separately) as reached and, furthermore, that neither Executive nor Employer have given notice of termination at the end of the bonus year (each 31 December), Employer shall within 20 business days after the date of the unrestricted audit report on the consolidated financial statements of Employer pay to Executive a bonus of 50% (at target) gross of the Annual Base Salary and pro rata.
Possible other cash payments by Employer in addition to salary and bonus are always made voluntarily and determined by Employer at his sole discretion.  Executive shall not have a right to receive any such additional payments and any payments made cannot be taken as a precedent for future or further payments.
5.    Long Term Incentive
Subject to the terms and conditions of the Long Term Incentive Plan then applicable for key executives of Nobel Biocare Group, Executive will be eligible for such incentives.  Details will be addressed in line with the applicable plan.  Earning perspectives in connection with Long-term Incentive Plan do not constitute a compensation for the work performed by Executive.  Rights and duties of Executive in connection with any such options are exclusively governed by the provisions of the applicable Long-term Incentive Plan and do not form part of this Agreement.
6.    Deductions
Executive’s contributions to the social insurances and pension scheme under applicable laws and regulations shall be deducted from the payments under sections 3 to 5 above.
7.    Expenses   
Employer shall compensate Executive for all expenses arising out of the performance of his duties under this Agreement, which are adequately supported by documentation.  The settlement shall be made as per the end of each month.  Executive is bound to adhere to Employer’s policy for expenses.
Executive is entitled to a tax free expense lump sum of currently CHF 1’750 (one thousand seven hundred and fifty Swiss Francs) per month.  The payment will be subject to the applicable expense policies approved by the responsible tax authorities and may change in line with changes to these policies.
8.    Vacation
Executive shall be entitled to 25 days paid vacation per calendar year on a pro rata basis. Execuive shall determine the time of vacation taking into account his duties.
9.    Sickness, Accident
Employer will reimburse Executive according to the “Orientiering über die kolektive Kranken-Lohnausfall- und Unfallversicherung für die Mitarbeiterlnnen der Nobel Biocare AG”.  The insurance premiums shall be paid by Employer.

Employment Agreement - Hans Geiselhöringer                            

10.    Pension scheme
Executive confirms having been informed about the existing social security protection and the apportionment of premiums.  The level of participation of Executive in the pension fund will be subject to formal decision by the relevant Swiss social security administration.
11.    Confidentiality
Executive shall treat as confidential and not disclose to others, or take or use for Executive’s own purposes or for the purposes of others, any business matters of Employer and Nobel Biocare Group (“Business Matters”).
Business Matters include manufacturing secrets, business secrets and all other facts that are relevant for the business and are not known to the public and are either of a confidential nature (such as addresses of employees, suppliers and customers, agreements and their terms and conditions, accounting figures and balance sheet figures etc.) or have been indicated to Executive as being confidential. 
This confidentiality obligation will remain effective after the termination of this Agreement without limitation and irrespective of the cause of termination.
Executive must keep in safe custody any documentation on Business Matters of Nobel Biocare Group and shall surrender it to Employer upon first request, at the latest at the end of this Agreement, and without keeping copies.  Wherever copies cannot be surrendered to Employer (e.g. digital copies, data carriers or the like) such copies must be destroyed at the time of request to surrender even if destruction of copies has not been specifically requested by Employer.
12.    Non-Competition and Non-Solicitation Obligation
These obligations are requested in a specific Appendix to this Agreement.
13.    Data Protection
Executive acknowledges and agrees that Employer may store, transfer, change and destroy all of his personal data in connection with this Agreement, in accordance with the relevant laws on data protection.
14.    Further activities 
Executive acknowledges and agrees that professional activities pursued outside the Nobel Biocare Group require Employer’s prior approval and will be decided on a case-by-case basis.
15.    Addenda
The following agreements form an integral part of this Employment Agreement:
		
	•
	Code of Conduct in its currently valid version

		
	•
	Expense Regulations (Spesenreglement)

		
	•
	Global Travel Policy for business trips

		
	•
	Employee Regulations (Switzerland)

Employment Agreement - Hans Geiselhöringer                            

16.    Amendments to Agreement, Applicable Law, Jurisdiction
No oral agreements exist in addition to this Agreement.  Any changes, any amendments or additions to this Agreement must be in writing.
Should any one or more provisions of this Agreement be or become invalid, the other provisions shall not be affected.  Invalid provisions shall be substituted with provisions which are most closely in line with the intended purpose. 
This Agreement shall be governed by the laws of Switzerland.
Any disputes arising out of this Agreement shall be submitted to the ordinary courts of Switzerland.
	
					
	Place, Date
	23 September 2014
	 
	 
	 

	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

	/s/ Richard Laube
	 
	/s/ Jörg von Manger-Koenig

	Richard Laube
	 
	 
	Jörg von Manger-Koenig

	CEO
	 
	 
	Executive Vice President Legal,

	 
	 
	 
	Compliance & Human Resources

	 
	 
	 
	 
	 

	/s/ Hans Geiselhöringer
	 
	 
	 

	Hans Geiselhöringer
	 
	 
	 

	Executive Vice President Global Research,
	 
	 

	Products & Development
	 
	 
	 

Employment Agreement - Hans Geiselhöringer                            

Hans Geiselhöringer
Hohenzollemstrasse 146
80796 München
Germany

Appendix to Section #12 of the Employment Agreement dated 23 September 2014, which states that the obligations of Non-Competition and Non-Solicitation are regulated in a specific Appendix:

		
	1.
	Executive shall not, for as long as he remains an Executive of Nobel Biocare and during a period of twelve (12) months after effective termination of his employment with Nobel Biocare (“Non-Competition Period”), alone, jointly with, as manager, as agent for or Executive of any person or as a shareholder directly or indirectly carry on or be engaged, concerned or interested in any business competitive to the business of Nobel Biocare with an effect in Switzerland, European Community or any other country for which Executive possesses and will possess knowledge of Confidential Information. 

Executive shall not during the Non-Competition Period (i) solicit, induce or attempt to induce any person who is an Executive of Nobel Biocare to leave Nobel Biocare or to engage in any business that competes with Nobel Biocare; (ii) hire or assist in the hiring of any person who is an Executive of Nobel Biocare to work for any Business that competes with Nobel Biocare; (iii) solicit, induce or attempt to induce any person or company that is a customer of Nobel Biocare to discontinue or modify its customer relationship with Nobel Biocare, or (iv) make in a private or public context statements about Nobel Biocare (or its customers, employees or other affiliates) which are harmful to its business or its reputation.  The leaving of an Executive or the modification of a customer relationship in itself does not constitute a violation of this section unless Executive has during the Non-Competition Period solicited, induced or attempted to induce such leaving or modification of customer relationship.
		
	2.
	During the twelve (12) months of non-competition and non-solicitation obligation after the effective termination of his employment agreement Nobel Biocare will continue to pay Executive’s last paid Annual Base Salary in twelve (12) equal monthly installments, provided that he fully complies with those obligations.  Executive may request Nobel Biocare to waive the post-contractual non-competition obligation; if Nobel Biocare agrees, the obligation to pay monthly installments ceases at this point in time and the Executive is released from all duties stipulated hereunder.  Nobel Biocare may not waive payment hereunder unless it is confirmed by an independent legal opinion that the obligation contained herein without the possibility to waive it by the company is contrary to the rules of the so-called Minder ordinance or any successor legislation.

		
	3.
	Executive is aware and acknowledges that a violation of his non-competition and non-solicitation obligation may seriously damage Nobel Biocare.  In case of violation of these obligations Executive shall pay liquidated damages of one Annual Base Salary.  In case of continued violation of the obligation not to compete and not to solicit liquidated damages in the afore-mentioned amount will become due every month as long as the Executive continues to violate.  Additionally, Nobel Biocare has the right to claim for any damage, which has been caused by violations of these obligations.  A payment of liquidated damages does not release Executive from his obligations of confidentiality, non-competition and non-solicitation.  Additionally, if 

Executive violates the obligation not to compete, Nobel Biocare shall be entitled to obtain a court’s order for specific performance, as well as adequate injunctive relief or any other adequate judicial measure, to immediately stop such violation (“Realexekution”).
		
	4.
	As from the settlement of the Danaher offer announced on September 15, 2014 the obligations of the Executive enumerated herein shall extend not only to Nobel Biocare but also to the dental business of the Danaher group.

		
	5.
	We herewith confirm our mutual agreement regarding the specific situation of your Employment Agreement with Nobel Biocare as follows:

		
	a.
	It is explicitly understood and agreed between Nobel Biocare Services AG and you, that you are the owner of Dental X Hans Geiselhöringer GmbH & Co. KG, Munich, Germany, and indirectly of Medtech Strategic Services AG, Küsnacht, Switzerland, and that these companys will continue to provide services to the nobel Biocare Group if so requested.

		
	b.
	The parties explicitly agree that you will be permitted to pursue your activities as global speaker on esthetical dental solutions and that you will provide services to third parties through Dental X Hans Geiselhöringer GmbH & Co. KG, Munich, Germany, and Medtech Strategic Services AG, Küsnacht, Switzerland.

We kindly ask you to confirm your agreement to the conditions of employment by countersigning below.
Your sincerely 
Nobel Biocare Services AG
	
					
	Place, Date
	23 September 2014
	 
	 
	 

	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

	/s/ Richard Laube
	 
	/s/ Jörg von Manger-Koenig

	Richard Laube
	 
	 
	Jörg von Manger-Koenig

	CEO
	 
	 
	Executive Vice President Legal,

	 
	 
	 
	Compliance & Human Resources

	 
	 
	 
	 
	 

	/s/ Hans Geiselhöringer
	 
	 
	 

	Hans Geiselhöringer
	 
	 
	 

	Executive Vice President Global Research,
	 
	 

	Products & Development
	 
	 
	 

AMENDMENT TO HANS GEISELHÖRINGER EMPLOYMENT AGREEMENT BETWEEN
(1)Nobel Biocare Services AG (“Company”) and
(2)Hans Geiselhöringer (“Executive”)
(Together, the “Parties”)
(“Amendment Agreement”)
The Parties agree to the following amendments of Executive’s employment agreement dated 23 September 2014 which includes the addendum to section 12 (collectively the “Employment Agreement”).  This Amendment Agreement shall come into effect upon the signature of the Executive.
The following provisions shall amend, replace or supersede existing provisions or terms of the Employment Agreement.  In the event of conflicting provisions, the terms and conditions of this Amendment Agreement shall prevail.
1.The parties agree that paragraph 4 of the Employment Agreement shall be deleted in its entirety and replaced with the following provision:
4. Short Term Incentive
As of 1 January 2015, Executive shall be eligible to participate in Danaher Corporation’s Incentive Compensation Program (ICP) with a target of 50% of the Annual Base Salary, subject to the ICP’s terms and conditions in effect from time to time.
The Incentive Compensation Plan is based on different components to be redefined by the Employer on an annual basis.  The relevant components and their respective weighting will be communicated annually.
2.The parties agree that paragraph 5 of the Employment Agreement shall be deleted in its entirety and replaced with the following provision:
5. Long Term Incentive
Executive’s treatment of current LTI awards of Nobel Biocare Group will be as provided in the 19 August 2014 determination by the Nomination and Compensation Committee.
Executive will be eligible to be recommended for equity awards as part of Danaher Corporation’s equity compensation program.  Any awards will be solely governed by the terms and conditions set forth in Danaher’s 2007 Stock Incentive Plan and in the particular form of award agreement required to be signed with respect to each award.  Any equity awards are discretionarily implemented without implying any custom or creating precedent of any kind.  Such equity award is not granted in compensation for Executive’s work, nor as an additional remuneration.  The parties expressly agree that any equity awards will not be considered for salary integration purposes.
3.In Appendix to Section 12 of the Employment Agreement, all references to “Nobel Biocare” shall be amended to “Nobel Biocare Group” as defined in the Employment Agreement.
The remaining terms of the Employment Agreement shall be unaffected by the changes stated above.
Any amendments and/or supplements to this Amendment Agreement or the Employment Agreement may be validly made only by a written annex to this Amendment Agreement that is signed by both Parties and is deemed to form part of this Amendment Agreement.
This Amendment Agreement is drawn up and signed in counterparts in duplicate, one copy for each party.

AGREED:

Signed for and on behalf of Nobel Biocare Services AG
	
					
	Signed:
	/s/ Richard Laube
	 
	Date:
	18 June 2015

	Print Name:
	Richard Laube
	 
	 
	 

	Title:
	 
	 
	 
	 

	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

	Signed:
	/s/ Hans Geiselhöringer
	 
	Date:
	18 June 2015

	 
	 
	 
	 
	 

AMENDMENT TO EMPLOYMENT AGREEMENT 
BETWEEN 
		
	(1)
	Nobel Biocare Services AG (the “Company”) and

		
	(2)
	Hans Geiselhöringer  (the “Employee”)

(“Amendment Agreement”) 
RECITALS
Danaher Corporation (“Danaher”) has announced that its Dental business will become a publicly traded company by way of an initial public offering (the “Dental IPO”), and it is anticipated the Dental IPO will be completed in late 2019.   
In anticipation of the Dental IPO, the parties agree to the following amendments of Employee’s employment contract and prior amendments thereto (collectively, the “Employment Contract”). This Amendment Agreement will take effect upon the closing of the Dental IPO (the “Closing”). Upon the Closing, the Company, along with other Danaher Dental operating companies, will be organized as one business, Envista Holdings Corporation (“Envista”).  
As of the Closing, the Employment Contract is hereby modified by the following provisions which shall amend the Employment Contract and, where applicable, replace or supersede existing provisions or terms concerning those subject matters:  
		
	1.
	JOB TITLE

The Employee’s Job title will be: Senior Vice President, Envista and President, Nobel Biocare Systems.
		
	2.
	INCENTIVE COMPENSATION

The Employee will eligible to participate in the Incentive Compensation Plan (“ICP”) with a target bonus of 70% of the Employee’s annual base salary, subject to periodic review. Normally, ICP payments are made during the first quarter of the following calendar year. This bonus is based on a Company Financial Factor and a Personal Performance Factor which are determined each year. The Employee will be paid his full 2019 bonus under the ICP by the Company in the normal course.
		
	3.
	CONFIDENTIALITY, INTELLECTUAL PROPERTY AND RESTRICTIVE COVENANTS  

The Employee must execute the accompanying Protection of Proprietary Rights Agreement (the “PPRA”), which is incorporated into this Agreement and forms part of the terms of Employee’s employment.  The Employee agrees that he will affirm his commitment to comply with the PPRA, or execute a replacement for the PPRA, each from time to time as the Company requires.    
		
	4.
	STANDARDS OF CONDUCT

The Employee agrees to abide by the Envista Standards of Conduct (the “Standards”), in effect and as amended from time to time, agrees to complete all related training as required, and agrees to annually recertify adherence to the Standards.

		
	5.
	GENERAL 

This Amendment Agreement supersedes all previous oral or written understandings or agreements, if any, made by or with the Company regarding the above amendments to the Employment Contract.  Further, the Employee acknowledges and agrees that he has not, will not and cannot rely on any representations not expressly made herein.
If any portion of this Amendment Agreement, the PPRA or the Employment Contract is held unenforceable, the parties agree that a court of competent jurisdiction may modify the agreement (by adding or removing language) or sever unenforceable provisions in order to render this Amendment Agreement or the PPRA enforceable to the fullest extent permitted by law. 
The remaining terms of the Employment Contract shall be unaffected by the changes listed above. 
Any amendments and/or supplements to this Amendment Agreement and the PPRA must be in writing.  
This Amendment Agreement shall be governed by laws of Switzerland.

Signed for and on behalf of Nobel Biocare Services AG 
	
				
	Signed:
	/s/ Amir Aghdaei
	 
	Date: 8/1/2019

	 
	 
	 
	 

	Print Name: Amir Aghdaei
	 
	 

	 
	 
	 
	 

	Title:
	DHR GE, Dental President
	 
	 

	 
	 
	 
	 

	I agree that my Employment Contract shall be varied by the revised terms set out in this Amendment Agreement.

	 
	 
	 
	 

	 
	 
	 
	 

	Signed:
	/s/ Hans Geiselhöringer
	 
	Date: 7/31/2019

	 
	Hans Geiselhöringer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}]]